BNET Industries
Last Fiscal Year Sales:$53.8M
- Public
- US
Dow Jones Description
Tutogen Medical, Inc., a Florida corporation, was formed in 1985 and with its consolidated subsidiaries (collectively, the "Company" or "Tutogen", develops, manufactures and markets sterile biological implant grafts made from human (allograft) and animal (xenograft) tissue. Tutogen utilizes its Tutoplast Process of tissue preservation and viral inactivation to manufacture and deliver sterile bio-implants used in dental, spinal, urology, ophthalmology, head and neck, and general surgery procedures. One of the Company's wholly owned subsidiaries, Tutogen Medical GmbH, designs, develops, processes, manufactures, markets, and distributes specialty surgical grafts and services to over 20 countries through a worldwide distribution network. Another subsidiary, Tutogen Medical (United States), Inc., was formed in 1994 to process, market and distribute allografts for the U.S. market.
Number of Employees 239
Contact Information
1130 McBride Ave 3rd Fl
West Paterson, New Jersey 07424
(973) 785-0004
Peer Companies
NAICS Code Surgical and Medical Instrument Manufacturing: 339112
Recent Events
-
RTI Biologics Announces 2009 Third Quarter Results
-
RTI Biologics Announces 2009 Second Quarter Results
News & Analysis
Filter by
tutogen medical inc. - All News and Analysis
Regeneration Technologies, Tutogen Medical Announce New Name for Proposed Merged Company
ALACHUA, Fla. -- Regeneration Technologies, Inc. RTI (Nasdaq:RTIX) and Tutogen Medical, Inc. (AMEX:TTG) today announced that with the proposed merger of the two companies, they will ask RTI shareholders to approve a new company name - RTI Biologics, Inc. The stock will continue to trade on the Nasdaq Global Market...
Regeneration Technologies, Tutogen Medical Set Special Meeting of Stockholders to Vote on Proposed Merger
ALACHUA, Fla. -- Regeneration Technologies, Inc. RTI (Nasdaq:RTIX) and Tutogen Medical, Inc. (AMEX:TTG) today announced that special meetings of stockholders have been set to vote on the proposed merger of the two companies. A special meeting of the stockholders of RTI, to consider and vote upon the transactions contemplated...
Tutogen Medical F4Q07 (Qtr End 09/30/2007) Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions Our first question is from the line of Matt Dolan with Roth Capital. Please go ahead with your question. Matt Dolan - Roth Capital Guys, can you hear me? Guy Mayer Sure, we can, Matt. Matt Dolan - Roth Capital Okay. Thanks. On the gross...
Regeneration Technologies, Tutogen Medical Announce Agreement to Merge
* Merger creates a leading global company in the biologics industry * Transaction expected to be accretive in 2008 earnings per share * Compelling strategic fit with highly complementary product lines and distributor mix, increasing growth and diversification * $5 million - $6 million of identified annual...
- 1
Industry Transcripts by Seeking Alpha
-
AtriCure, Inc. Q3 2009 Earnings Call Transcript
on Nov 04, 2009about ATRC
-
Unum Group Q3 2009 Earnings Call Transcript
on Nov 04, 2009about UNM
-
DaVita Inc. Q3 2009 Earnings Call Transcript
on Nov 03, 2009about DVA
-
Tenet Healthcare Corporation Q3 2009 Earnings Call Transcript
on Nov 03, 2009about THC
-
The Principal Financial Group Q3 2009 Earnings Call Transcript
on Nov 03, 2009about PFG
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Physicians Know We Need Reform 4 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes


